• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
How effective is effective enough? Opinions of potential end-users of microbicides from a rural South African community.怎样才算足够有效?来自南非农村社区的杀微生物剂潜在终端用户的看法。
AIDS Care. 2013;25(5):573-8. doi: 10.1080/09540121.2012.722604. Epub 2012 Sep 13.
2
Communicating about microbicides with women in mind: tailoring messages for specific audiences.关注女性视角,宣传杀微生物剂:为特定受众定制信息。
J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19151. doi: 10.7448/IAS.17.3.19151. eCollection 2014.
3
Microbicides and HIV: help or hindrance?杀微生物剂与艾滋病病毒:助力还是阻碍?
J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):71-5. doi: 10.1097/00126334-200309010-00011.
4
Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.让男性伴侣参与女性使用杀微生物剂:临床试验证据及其对未来研究和杀微生物剂推广的意义。
J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19159. doi: 10.7448/IAS.17.3.19159. eCollection 2014.
5
Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.优化针对女性的艾滋病预防措施:杀微生物剂研究证据综述及引入对性别敏感的杀微生物剂的考量
J Int AIDS Soc. 2015 Dec 21;18(1):20536. doi: 10.7448/IAS.18.1.20536. eCollection 2015.
6
Shifts in condom use following microbicide introduction: should we be concerned?引入杀微生物剂后避孕套使用情况的变化:我们应该担心吗?
AIDS. 2003 May 23;17(8):1227-37. doi: 10.1097/00002030-200305230-00015.
7
Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省夫妻间关于杀微生物剂使用的交流
AIDS Behav. 2015 May;19(5):832-46. doi: 10.1007/s10461-014-0965-y.
8
Perceptions of acceptability and utility of microbicides in Ghana, West Africa: a qualitative, exploratory study.对西非加纳杀微生物剂可接受性和效用的认知:一项定性探索性研究。
SAHARA J. 2008 Apr;5(1):11-8. doi: 10.1080/17290376.2008.9724897.
9
Blockage and flow: intimate experiences of condoms and microbicides in a South African clinical trial.阻塞与流动:南非临床试验中对避孕套和杀微生物剂的亲密体验。
Cult Health Sex. 2011 Jan;13(1):31-44. doi: 10.1080/13691058.2010.511270.
10
An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.加纳农村地区女性对预防 HIV 的阴道杀微生物剂的可接受性评估。
BMC Womens Health. 2012 Nov 1;12:40. doi: 10.1186/1472-6874-12-40.

引用本文的文献

1
Forming and implementing community advisory boards in low- and middle-income countries: a scoping review.在中低收入国家组建和实施社区咨询委员会:范围综述。
BMC Med Ethics. 2019 Oct 17;20(1):73. doi: 10.1186/s12910-019-0409-3.
2
Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence.利益相关者参与以告知 HIV 临床试验:证据的系统评价。
J Int AIDS Soc. 2018 Oct;21 Suppl 7(Suppl Suppl 7):e25174. doi: 10.1002/jia2.25174.
3
Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.南非关键人群中脆弱性背景与新型生物医学艾滋病毒预防技术的可接受性:一项定性研究。
PLoS One. 2018 Feb 8;13(2):e0191251. doi: 10.1371/journal.pone.0191251. eCollection 2018.
4
How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa.我们真正能期待对新型艾滋病毒预防技术有多大需求?来自南非一项离散选择实验的结果。
PLoS One. 2013 Dec 30;8(12):e83193. doi: 10.1371/journal.pone.0083193. eCollection 2013.

本文引用的文献

1
Preexposure prophylaxis for HIV infection among African women.预防非洲女性感染 HIV 的暴露前预防措施。
N Engl J Med. 2012 Aug 2;367(5):411-22. doi: 10.1056/NEJMoa1202614. Epub 2012 Jul 11.
2
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.博茨瓦纳异性传播 HIV 中抗逆转录病毒的预先暴露预防。
N Engl J Med. 2012 Aug 2;367(5):423-34. doi: 10.1056/NEJMoa1110711. Epub 2012 Jul 11.
3
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.抗逆转录病毒预防治疗用于异性恋男性和女性的 HIV 预防。
N Engl J Med. 2012 Aug 2;367(5):399-410. doi: 10.1056/NEJMoa1108524. Epub 2012 Jul 11.
4
Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence.基于替诺福韦的 HIV 暴露前预防:不断发展的证据。
Curr Opin Infect Dis. 2012 Feb;25(1):51-7. doi: 10.1097/QCO.0b013e32834ef5ef.
5
A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel.一种多隔室、单次和多次给药的阴道候选杀微生物剂 1%替诺福韦凝胶的药代动力学研究。
PLoS One. 2011;6(10):e25974. doi: 10.1371/journal.pone.0025974. Epub 2011 Oct 19.
6
The future of microbicides.杀微生物剂的未来。
Int J Infect Dis. 2011 Oct;15(10):e656-60. doi: 10.1016/j.ijid.2011.05.001. Epub 2011 Jun 25.
7
Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa.替诺福韦凝胶对南非艾滋病流行的流行病学影响。
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):207-10. doi: 10.1097/QAI.0b013e3182253c19.
8
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women.BufferGel 和 0.5% PRO2000 凝胶预防女性 HIV 感染的安全性和有效性。
AIDS. 2011 Apr 24;25(7):957-66. doi: 10.1097/QAD.0b013e32834541d9.
9
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.男男性行为人群 HIV 预防的暴露前药物预防。
N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.
10
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.PRO2000 阴道凝胶预防 HIV-1 感染(杀微生物剂开发计划 301):一项 3 期、随机、双盲、平行组试验。
Lancet. 2010 Oct 16;376(9749):1329-37. doi: 10.1016/S0140-6736(10)61086-0. Epub 2010 Sep 17.

怎样才算足够有效?来自南非农村社区的杀微生物剂潜在终端用户的看法。

How effective is effective enough? Opinions of potential end-users of microbicides from a rural South African community.

作者信息

Gafos Mitzy, Mzimela Misiwe A, Ndlovu Hlengiwe B, McCormack Sheena, McGrath Nuala

机构信息

The Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa.

出版信息

AIDS Care. 2013;25(5):573-8. doi: 10.1080/09540121.2012.722604. Epub 2012 Sep 13.

DOI:10.1080/09540121.2012.722604
PMID:22971053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3630452/
Abstract

To assess the views of potential end-users of a microbicide in KwaZulu-Natal regarding the characteristics that would justify further development, three focus group discussions were conducted in 2009 with 23 local staff members working on a microbicide clinical trial, 20 former trial participants and 14 Community Advisory Board members not enrolled in the trial, in an area with high HIV incidence and low consistent condom use. All participants agreed on the need for additional HIV prevention options that are as effective as possible and can be used by women. The majority of respondents stated that even a highly acceptable HIV prevention option with protection as low as 30% would still be an important addition to condoms for women; that a partially protective microbicide would have to be introduced as part of the existing prevention messages in order to continue promoting condom use; that there should eventually be a choice between antiretroviral (ARV) and non-ARV-based microbicides and a choice of how and where to access microbicides. Respondents also felt it would be important to make plans for access to a microbicide that can offer protection, even if partial, rather than wait to find out if alternative microbicides are equally or more effective. Potential end-users in a high HIV prevalence area believe that a partially effective microbicide would be an important addition to the limited HIV prevention options for women. The significant challenges of introducing a partially protective HIV prevention option were recognised, but seen as ones worth facing, as well as an opportunity to lay the ground work for the introduction of more efficacious HIV prevention methods in the future.

摘要

为了评估夸祖鲁 - 纳塔尔省一种杀微生物剂潜在终端用户对于那些能够证明进一步研发合理性的特性的看法,2009年开展了三场焦点小组讨论,参与者包括23名参与杀微生物剂临床试验的当地工作人员、20名前试验参与者以及14名未参与试验的社区咨询委员会成员,该地区艾滋病毒感染率高且避孕套持续使用率低。所有参与者都认同需要有更多尽可能有效的艾滋病毒预防选择,并且这些选择要可供女性使用。大多数受访者表示,即使是一种接受度很高但保护率低至30%的艾滋病毒预防选择,对女性而言仍是避孕套之外的一项重要补充;一种具有部分保护作用的杀微生物剂必须作为现有预防信息的一部分引入,以便继续推广避孕套的使用;最终应该在基于抗逆转录病毒药物(ARV)和非ARV的杀微生物剂之间做出选择,以及在如何获取和何处获取杀微生物剂方面做出选择。受访者还认为,即便杀微生物剂只能提供部分保护,也要制定获取计划,而不是等着看其他杀微生物剂是否同样有效或更有效,这一点很重要。艾滋病毒高流行地区的潜在终端用户认为,一种部分有效的杀微生物剂将是女性有限的艾滋病毒预防选择中的一项重要补充。引入一种具有部分保护作用的艾滋病毒预防选择所面临的重大挑战是公认的,但这些挑战被视为值得面对,同时也是为未来引入更有效的艾滋病毒预防方法奠定基础的一个契机。